Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

NCT02769962 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

NIH

Sponsor class

Conditions

Urothelial Carcinoma
Urothelial Cancer
Lung Neoplasms
Small Cell Lung Cancer
Prostate Cancer

Interventions

DRUG: EP0057
DRUG: olaparib
DIAGNOSTIC_TEST: CT scan
DIAGNOSTIC_TEST: CT chest, abdomen, and pelvis
DIAGNOSTIC_TEST: Bone scan
DIAGNOSTIC_TEST: ECG
DIAGNOSTIC_TEST: Echocardiogram
PROCEDURE: Biopsy

Sponsor

National Cancer Institute (NCI)